IMPACT OF LONG-TERM TENOFOVIR DISOPROXIL FUMARATE TREATMENT ON HEPATIC LIPID METABOLISM IN MOUSE

被引：0
|
作者：
Duan, Yuanqin [1 ]
Chen, Zhiwei [1 ]
Hu, Peng [1 ]
机构：
[1] Chongqing Med Univ, Inst Viral Hepatitis, Affiliated Hosp 2,Minist Educ, Dept Infect Dis,Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1173
引用
收藏
页码：S291 / S292
页数：2
相关论文
共 50 条
  • [1] Impact of long-term tenofovir disoproxil fumarate treatment on bone metabolism and skeletal muscle function in mouse
    Chen, Z-W
    Li, Z.
    Luo, A-R
    Hu, P.
    Ren, H.
    Luo, Y-X.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S701 - S702
  • [2] Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
    Woldemedihn, Gezahegn M.
    Aberra, Hanna
    Desalegn, Hailemichael
    Berhe, Nega
    Belay, Denekew Bitew
    Rueegg, Corina S.
    Johannessen, Asgeir
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [3] Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, W. Ray
    Loomba, Rohit
    Berg, Thomas
    Schall, Raul E. Aguilar
    Yee, Leland J.
    Dinh, Phillip V.
    Flaherty, John F.
    Martins, Eduardo B.
    Therneau, Terry M.
    Jacobson, Ira
    Fung, Scott
    Gurel, Selim
    Buti, Maria
    Marcellin, Patrick
    CANCER, 2015, 121 (20) : 3631 - 3638
  • [4] Clinical Efficacy and Safety of Long-Term Treatment of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for Chronic Hepatitis B in Vietnam
    Nguyen, Thao Huynh Phuong
    Bui, Quynh Thi Huong
    Vo, Thong Duy
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (10)
  • [5] Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
    Villa, Giovanni
    Phillips, Richard O.
    Smith, Colette
    Stockdale, Alexander J.
    Ruggiero, Alessandra
    Beloukas, Apostolos
    Appiah, Lambert T.
    Chadwick, David
    Sarfo, Fred S.
    Geretti, Anna Maria
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) : 3148 - 3157
  • [6] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients
    Butt, N.
    Rai, L.
    Hussain, R.
    Khemani, H.
    Ali, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 84 - 84
  • [7] Tenofovir disoproxil fumarate for the treatment of HIV infection
    Pham, Paul A.
    Gallant, Joel E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (03) : 459 - 469
  • [8] LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA
    Kim, W. R.
    Berg, T.
    Loomba, R.
    Schall, R. Aguilar
    Dinh, P.
    Yee, L. J.
    Martins, E. B.
    Flaherty, J. F.
    Gurel, S.
    Buti, M.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S19 - S19
  • [9] Long term tenofovir disoproxil fumarate (TDF) therapy and the risk of hepatocellular carcinoma
    Sievert, W.
    Strasser, S.
    Gane, E.
    George, J.
    Weilert, F.
    Flaherty, J. F.
    Dinh, P.
    Schall, R. A.
    Martins, E. B.
    Yee, L.
    Marcellin, P.
    Kim, W. R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 53 - 54
  • [10] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Monotherapyfor Multidrug-Resistant Chronic Hepatitis B
    Lee, Hye Won
    Park, Junyong
    Lee, Jin-Woo
    Yoon, Ki Tae
    Kim, Chang Wook
    Park, Hana
    Kim, Young Seok
    Baik, Soon Koo
    Lee, Jung Il
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    Ahn, Sang Hoon
    Ahn, Sang Hoon
    HEPATOLOGY, 2018, 68 : 233A - 234A
12345